Planned Parenthood of Indiana has cut 25 jobs and will close six health centers around the state as part of a restructuring
it attributed to a decline in federal funding.
Idaho is getting $13 million as part of a settlement reached with Indianapolis-based Eli Lilly and Co. over its marketing of
anti-psychotic drug Zyprexa.
Nearly 700 workers will be offered severance, new jobs
Presenting five video excerpts from a free-wheeling panel discussion about health-care reform featuring five of the city’s
top minds and decision-makers. Reporter J.K. Wall moderates the IBJ’s Power Breakfast on Sept. 25, covering tort reform,illegal
immigrants, pay models and the role of insurance companies.
UnitedHealthcare has become the second health insurer to join Quality Health First, a pay-for-performance program operated
by the Indiana Health Information Exchange, the exchange announced Tuesday.
The insurance industry sharply escalated its criticism of the Senate health care bill Sunday, charging that the legislation
would shift costs to privately insured people, raising the price of a typical policy by hundreds, if not thousands, of dollars
annually.
Shares of WellPoint Inc. partially recovered Friday morning after a plunge was touched off Thursday by gathering momentum behind health care reform and talk of a windfall-profit tax by Speaker of the House Nancy Pelosi.
With a national unemployment rate of nearly 10 percent eroding its customer base, WellPoint Inc. is cutting at least 30
middle-management employees and reshuffling its corporate organization, according to internal memos obtained by IBJ.
The health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.
The business park would encompass about 900 acres on the town’s northeast side and require rezoning
of much of the land, from residential and agriculture to commercial.
The company, which guides working adults and their parents through the maze of decisions and agencies involved in care for seniors, plans to use the money primarily to augment its sales staff and operations.
Demonstrators on Wednesday backed Maine’s insurance superintendent for rejecting a request from the state’s largest private health insurer seeking an 18-percent rate hike for its individual insurance plans.
The new president of Community Hospital East says her job is all about health—the health of not just patients, but
the entire neighborhood.
Dow AgroSciences’ introduction of a promising new product is helping transform the Indianapolis company as it transitions
from a focus on traditional agricultural chemicals to genetically altered seeds. The subsidiary of Michigan-based Dow Chemical
Co. partnered with St. Louis-based Monsanto Co. to develop what could become its biggest blockbuster, a genetically modified
corn variety it calls SmartStax.
BioCrossroads, an Indianapolis-based not-for-profit, is cataloging Indiana businesses offering contract services to pharmaceutical
and biotechnology companies, and discovering many small firms operating in relative obscurity.
Eli Lilly and Co. has agreed to settle the State of South Carolina’s lawsuit that claimed Lilly improperly marketed the antipsychotic
drug Zyprexa, according to Bloomberg News.
Dow AgroSciences could boost its market share in genetically altered corn almost overnight by inventing a perennial corn.
But investors might not have the patience.
Fishers development officials hope to create a huge cluster of medical and research facilities near Interstate 69’s Exit
10, near St. Vincent Medical Center Northeast, but local real estate experts disagree about the amount of potential demand
for such a development.
Health reform that would cover millions of uninsured Americans would theoretically send a flood of new
patients to physicians. Yet in Indiana and nationwide, there’s already a shortage of doctors.
Researchers at IUPUI have been awarded more than $22.3 million in grants by the National Institutes of Health, according to
U.S. Rep. Andre Carson. The money is part of a $5 billion program that was part of the federal stimulus bill approved earlier
this year, and will fund medical research across the country.
